Medicines Development for Global Health

11 clinical trials · Sponsor

Record	Firm	Date
Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction (NCT07172659)	Medicines Development for Global Health	2026-05-25
Better Options for Lymphatic Filariasis Treatment (NCT07159373)	Medicines Development for Global Health	2026-03-01
Efficacy and Safety Study of Moxidectin in Adults With Scabies (NCT05875441)	Medicines Development for Global Health	2023-11-23
Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis (NCT03876262)	Medicines Development for Global Health	2021-05-03
Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole (NCT04311671)	Medicines Development for Global Health	2021-05-03
A Pharmacokinetic and Safety Study of Moxidectin to Identify an Optimal Dose for Treatment of Children 4 to 11 Years (NCT03962062)	Medicines Development for Global Health	2021-03-29
Dose-finding Study of Moxidectin for Treatment of Scabies (NCT03905265)	Medicines Development for Global Health	2020-01-13

Every clearance here is in the API, with alerts when new ones post.